Table 4.
Characteristic | Number (percentage) |
---|---|
Overall level of reporting | |
Complete reportingb | 2 (8%) |
Incomplete reportingc | 23 (92%) |
Reports number of patients excluded during run-in period | |
Yes | 13 (52%) |
No | 12 (48%) |
Reports reasons for exclusion of patients | |
Yes | 7 (28%) |
No | 18 (72%) |
Reports baseline characteristics for excluded patients | |
Yes | 2 (8%) |
No | 22 (88%) |
Uncleard | 1 (4%) |
Notes:
Absolute numbers are shown, as well as percentages in parentheses. A trial run-in period was completely reported if the publication clearly described 1) the number of excluded patients, 2) reasons for exclusion and 3) baseline characteristics of the excluded patients.
Two publications reported trials with run-in periods, but stated to have no exclusions during this phase. They were, therefore, deemed to be completely reported on all three criteria.
One publication was a rationale and design paper reporting on a trial where patient recruitment and randomization was completed. The publication did not present information on the trial’s 2-week run-in period. We deemed reporting to be incomplete for all three criteria.
Data were not presented, but excluded and randomized patients were stated to be similar.